Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer
- PMID: 21481617
- DOI: 10.1016/j.urolonc.2011.02.020
Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer
Abstract
Objectives: Inguinal lymph node dissection (ILND) for the treatment of metastatic penile squamous cell carcinoma (SCC) has historically been associated with significant morbidity. This review addresses the surgical principles and techniques to decrease its perioperative morbidity, while optimizing its oncologic outcomes.
Materials and methods: A review of the English scientific literature from 1966 to present was conducted using the PubMed search engine as well as of additional cited works not initially noted in the search using as keywords penile cancer, inguinal lymph node dissection, inguinal lymph node metastasis, morbidity, and complications.
Results: The contemporary outcomes of ILND in the context of penile cancer have built on the significant contributions made by surgeons and scientists worldwide. In this review, we provide a comprehensive overview of the principles of ILND optimizing oncological outcomes, while minimizing its attributable morbidity. It is hoped this review will serve as a benchmark for clinicians to approach this often highly aggressive tumor phenotype.
Conclusions: ILND remains an important diagnostic and therapeutic procedure for patients with penile SCC, as contemporary ILND series have reported a decrease in its associated morbidity, with the potential for further treatment outcomes in years to come. ILND can in appropriately selected patients render them disease-free, thus justifying its associated morbidity.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Management of the lymph nodes in penile cancer.Urology. 2010 Aug;76(2 Suppl 1):S43-57. doi: 10.1016/j.urology.2010.03.001. Urology. 2010. PMID: 20691885 Review.
-
Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection?Onkologie. 2005 Mar;28(3):135-8. doi: 10.1159/000083585. Onkologie. 2005. PMID: 15772463
-
Lymphadenectomy in the surgical management of penile cancer.Eur Urol. 2009 May;55(5):1075-88. doi: 10.1016/j.eururo.2009.02.021. Epub 2009 Feb 23. Eur Urol. 2009. PMID: 19264390 Review.
-
The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.Urol Oncol. 2018 Dec;36(12):526.e1-526.e6. doi: 10.1016/j.urolonc.2018.09.014. Epub 2018 Nov 13. Urol Oncol. 2018. PMID: 30446445
-
Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.Eur Urol. 2010 Apr;57(4):688-92. doi: 10.1016/j.eururo.2009.07.004. Epub 2009 Jul 17. Eur Urol. 2010. PMID: 19647926
Cited by
-
Current Management Strategy for Penile Cancer and Future Directions.Curr Oncol Rep. 2017 Aug;19(8):54. doi: 10.1007/s11912-017-0615-4. Curr Oncol Rep. 2017. PMID: 28664471 Free PMC article. Review.
-
Floating patella associated with lymphoedema.J Surg Case Rep. 2015 Mar 22;2015(3):rjv026. doi: 10.1093/jscr/rjv026. J Surg Case Rep. 2015. PMID: 25802253 Free PMC article.
-
Simultaneous Bilateral Video-Endoscopic Inguinal Lymphadenectomy for Penile Carcinoma: Surgical Setting, Feasibility, Safety, and Preliminary Oncological Outcomes.J Clin Med. 2023 Nov 23;12(23):7272. doi: 10.3390/jcm12237272. J Clin Med. 2023. PMID: 38068324 Free PMC article.
-
Contemporary management of patients with penile cancer and lymph node metastasis.Nat Rev Urol. 2017 Jun;14(6):335-347. doi: 10.1038/nrurol.2017.47. Epub 2017 Apr 11. Nat Rev Urol. 2017. PMID: 28401957 Review.
-
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients.Int Immunopharmacol. 2021 May;94:107481. doi: 10.1016/j.intimp.2021.107481. Epub 2021 Feb 23. Int Immunopharmacol. 2021. PMID: 33636562 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials